HCPCS code J3263 — Inj, toripalimab-tpzi, 1 mg. Status: Active. Effective Jul 1, 2024. Source: CMS HCPCS Level II.

J3263

Active

Inj, toripalimab-tpzi, 1 mg

Injection, toripalimab-tpzi, 1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jul 1, 2024
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0745

MUE — Medically Unlikely Edits

Maximum units of J3263 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 480
Outpatient Hospital 480
Practitioner Services 480

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
70114-0340-01 Loqtorzi

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2024-Q3
    Inj, toripalimab-tpzi, 1 mg